ALPINE IMMUNE SCIENCES INC revenue for the last year amounted to 53.34 M EUR, the most of which — 53.34 M EUR — came from its highest performing source at the moment, Protein-based Immunotherapies, the year earlier bringing 28.09 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ALPINE IMMUNE SCIENCES INC 53.34 M EUR, and the year before that — 28.09 M EUR.